Basil Leaf Technologies
Technology: DxtER mobile health assessment platform
Founders: Basil Harris and George Harris
DxtER (pronounced Dexter) is the 2017 winner of the Qualcomm Tricorder XPrize, which seeks a device that will allow a user to assess health conditions anywhere and determine if they need further professional help. DxtER, developed by Basil Leaf Technologies under the Final Frontier Medical Devices team name, is a “tricorder” prototype that uses an artificial intelligence–based engine that learns to diagnose medical conditions by integrating learnings from clinical emergency medicine with data analysis from actual patients. It features non-invasive sensors that collect vital signs, body chemistry and biological functions. Algorithms diagnose 34 health conditions, including diabetes, atrial fibrillation, chronic obstructive pulmonary disease, urinary tract infection, sleep apnea, leukocytosis, pertussis, stroke, tuberculosis and pneumonia.
DxtER is the result of 4 years of development efforts within the Qualcomm Tricorder XPrize group. As the winner of the prize, the Final Frontier Medical team will get support from FDA and other regulatory bodies to develop the product and continue with R&D and testing. The initiatives of the prize committee include fast-tracking international retail distribution.